Actym Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 30
Rang # Quantité totale PI 47 714
Note d'activité PI 2,3/5.0    25
Rang # Activité PI 31 911

Brevets

Marques

14 0
9 0
7 0
0
 
Dernier brevet 2024 - Immunostimulatory bacteria for c...
Premier brevet 2018 - Engineered immunostimulatory bac...

Derniers inventions, produits et services

2024 Invention Immunostimulatory bacteria for converting macrophages into a phenotype amenable to treatment, and...
2022 Invention Engineered immunostimulatory bacterial strains and uses thereof. Provided are delivery immunosti...
Invention Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tu...
Invention Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platforms. Provided ar...
2021 Invention Engineered immunostimulatory bacterial strains and uses thereof. Provided are immunostimulatory b...
Invention Engineered immunostimulatory bacterial strains and uses thereof. Provided are immunostimulatory ...
Invention Immunostimulatory bacteria-based vaccines, therapeutics, and rna delivery platforms. Provided are...
Invention Immunostimulatory bacteria delivery platforms and their use for delivery of therapeutic products....
2019 Invention Engineered immunostimulatory bacterial strains and uses thereof. Salmonella species, are modified...
Invention Engineered immunostimulatory bacterial strains and uses thereof. Provided are delivery immunostim...
Invention Engineered immunostimulatory bacterial strains and uses thereof. pagPpagPpagP to produce inactive...
2018 Invention Engineered immunostimulatory bacterial strains and uses thereof. Salmonella species, which are mo...